Concepedia
Statistics
Publications
12
Citations
505
H-Index
Active since
2017
Affiliations
Weizmann Institute of Science(Current)
Technion – Israel Institute of Technology
Heidelberg University
German Cancer Research Center
University of California, San Francisco
Ashish Noronha is an author at Weizmann Institute of Science specializing in molecular oncology, oncology, and medicine.
Publications per year
2017–2025
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 103 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways
Donatella Romaniello, Luigi Mazzeo, Maicol Mancini et al. · Clinical Cancer Research · 2018 · 85 citations · Full text
Medicine, Oncology, Pharmacology +17
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
L. E. Roth, Swati Srivastava, Moshit Lindzen et al. · Science Signaling · 2018 · 57 citations · Full text
Life Sciences, Cancer Biology, Cell Biology +17
An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors
Maicol Mancini, Hilah Gal, Nadège Gaborit et al. · EMBO Molecular Medicine · 2017 · 56 citations · Full text
Pharmacy, Molecular Biology, Oncology +17
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
Soma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha et al. · Cell Reports · 2021 · 44 citations · Full text
Medicine, Cancer Biology, Oncology +13
1–5 of 12